ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,235.48
-0.60%
US Tech 100
18,024.00
-1.28%
Dow Jones
38,111.48
-0.86%
Brent Oil
81.95
-1.71%
Bitcoin
68,352.74
1.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) News

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPTH
DateTimeSourceHeadlineSymbolCompany
05/30/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
05/24/20247:00AMGlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
05/23/20245:00PMGlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:50AMIH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
05/14/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
05/08/20247:00AMGlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
04/19/202412:14PMGlobeNewswire Inc.Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
04/18/20241:57PMGlobeNewswire Inc.Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
04/18/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) PatientsNASDAQ:BPTHBio Path Holdings Inc
04/15/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
04/02/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Provides 2024 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
03/11/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
03/08/20245:11PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
03/08/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
03/08/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Reports Full Year 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
03/08/20246:22AMIH Market NewsU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices DipNASDAQ:BPTHBio Path Holdings Inc
03/07/20244:21PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BPTHBio Path Holdings Inc
03/01/20247:00AMGlobeNewswire Inc.Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024NASDAQ:BPTHBio Path Holdings Inc
02/29/20246:00AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BPTHBio Path Holdings Inc
02/23/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
02/21/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Announces 1-for-20 Reverse Stock SplitNASDAQ:BPTHBio Path Holdings Inc
02/02/20244:39PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BPTHBio Path Holdings Inc
02/02/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
01/23/20245:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
01/23/20244:51PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
01/17/20244:52PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
01/10/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
01/10/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia PatientsNASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
KEGS
1812 Brewing (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
GRLT
Grillit (PK)
USOTC
AHRO
Authentic (CE)
USOTC
AFFU
Affluence (PK)
USOTC
HHSE
Hannover House (PK)
NASDAQ
AGBA
AGBA
USOTC
ENZC
Enzolytics (PK)
USOTC
ASKH
Astika (PK)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
IOVA
Iovance Biotherapeutics
NASDAQ
RNAZ
TransCode Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved